QRISK3 (10-year CVD Risk)
iatroX editorial team · Updated · Record checked · editorial policy
QRISK3 estimates the 10-year risk of cardiovascular disease (heart attack or stroke) for adults aged 25–84 in the UK. It is the NICE-recommended CVD risk tool and uses clinical, demographic, and deprivation data including conditions not captured by other risk scores (SLE, atypical antipsychotics, migraine, erectile dysfunction, severe mental illness).
calculate with the official tool
Use the official calculator for this model, then return here for interpretation and related guidance.
Open the official QRISK3 calculator ↗evidence
derivation
Developed by Hippisley-Cox et al. (BMJ 2017) from the QResearch database of >10 million UK primary care patients. Updated from QRISK2 to include additional risk factors (SLE, migraine, antipsychotics, corticosteroids, erectile dysfunction, severe mental illness, CKD).
validation
Validated in 2.1 million patients separate from the derivation cohort. Well calibrated across age groups, ethnicities, and deprivation quintiles in the UK population. AUROC ~0.86 for women, ~0.84 for men.
guideline endorsements
NICE NG238 recommends QRISK3 for primary cardiovascular risk assessment in eligible adults and offering a statin at a 10-year risk of 10% or more, following shared decision making.
regional interpretation
references
- Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.PMID: 28536104
- NICE Clinical Guideline CG181. Cardiovascular disease: risk assessment and reduction, including lipid modification. 2014 (updated 2023).link ↗
- Supporting guidance — qrisk.org (checked 14 November 2026).link ↗
- Supporting guidance — nice.org.uk (checked 14 November 2026).link ↗